Characterization of FUS Mutations in Amyotrophic Lateral Sclerosis Using RNA-Seq
Name
Blitterswijk-2013-Characterization of.pdf
Size
304.58 KB
Format
Adobe PDF
Checksum (MD5)
87081f3f20b0b823571c2ad0fbcf8540
Author(s)
van Blitterswijk, Marka
Wang, Eric T.
Friedman, Brad Aaron
Keagle, Pamela J.
Lowe, Patrick
Leclerc, Ashley Lyn
van den Berg, Leonard H.
Housman, David E.
Veldink, Jan H.
Landers, John E.
Date Issued
April 2013
Journal
PLoS ONE
Publisher
Public Library of Science
Citation
van Blitterswijk, Marka, Eric T. Wang, Brad A. Friedman, Pamela J. Keagle, Patrick Lowe, Ashley Lyn Leclerc, Leonard H. van den Berg, David E. Housman, Jan H. Veldink, and John E. Landers. Characterization of FUS Mutations in Amyotrophic Lateral Sclerosis Using RNA-Seq. Edited by Huaibin Cai. PLoS ONE 8, no. 4 (April 8, 2013): e60788.
Version
Final published version
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease resulting in severe muscle weakness and eventual death by respiratory failure. Although little is known about its pathogenesis, mutations in fused in sarcoma/translated in liposarcoma (FUS) are causative for familial ALS. FUS is a multifunctional protein that is involved in many aspects of RNA processing. To elucidate the role of FUS in ALS, we overexpressed wild-type and two mutant forms of FUS in HEK-293T cells, as well as knocked-down FUS expression. This was followed by RNA-Seq to identify genes which displayed differential expression or altered splicing patterns. Pathway analysis revealed that overexpression of wild-type FUS regulates ribosomal genes, whereas knock-down of FUS additionally affects expression of spliceosome related genes. Furthermore, cells expressing mutant FUS displayed global transcription patterns more similar to cells overexpressing wild-type FUS than to the knock-down condition. This observation suggests that FUS mutants do not contribute to the pathogenesis of ALS through a loss-of-function. Finally, our results demonstrate that the R521G and R522G mutations display differences in their influence on transcription and splicing. Taken together, these results provide additional insights into the function of FUS and how mutations contribute to the development of ALS.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Biology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1371/journal.pone.0060788
